{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:04:16Z","timestamp":1790615056726,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310,030\u2013189,044"],"award-info":[{"award-number":["310,030\u2013189,044"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.cellsig.2020.109703","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T19:42:50Z","timestamp":1593546170000},"page":"109703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Targeting chloride transport in autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"73","author":[{"given":"Fran\u00e7ois","family":"Jouret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3744-4767","authenticated-orcid":false,"given":"Olivier","family":"Devuyst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2020.109703_bb0005","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(15)60907-2","article-title":"Autosomal dominant polycystic kidney disease: the changing face of clinical management","volume":"385","author":"Ong","year":"2015","journal-title":"Lancet."},{"key":"10.1016\/j.cellsig.2020.109703_bb0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2017050483","article-title":"Genetic complexity of autosomal dominant polycystic kidney and liver diseases","volume":"29","author":"Cornec-Le Gall","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.krcp.2014.05.002","article-title":"Cyst growth, polycystins, and primary cilia in autosomal dominant polycystic kidney disease","volume":"33","author":"Lee","year":"2014","journal-title":"Kidney Research and Clinical Practice."},{"key":"10.1016\/j.cellsig.2020.109703_bb0020","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41581-018-0051-1","article-title":"Metabolism and mitochondria in polycystic kidney disease research and therapy","volume":"14","author":"Padovano","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41581-019-0143-6","article-title":"Structure and function of polycystins: insights into polycystic kidney disease","volume":"15","author":"Douguet","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0030","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00467-018-4004-5","article-title":"Oxidative stress in autosomal dominant polycystic kidney disease: player and\/or early predictor for disease progression?","volume":"34","author":"Andries","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0035","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41581-019-0183-y","article-title":"The pathobiology of polycystic kidney disease from a metabolic viewpoint","volume":"15","author":"Menezes","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0040","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ajhg.2016.05.004","article-title":"Mutations in GANAB, encoding the Glucosidase IIalpha subunit, cause autosomal-dominant polycystic kidney and liver disease","volume":"98","author":"Porath","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cellsig.2020.109703_bb0045","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1172\/JCI90129","article-title":"Isolated polycystic liver disease genes define effectors of polycystin-1 function","volume":"127","author":"Besse","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2020.109703_bb0050","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ajhg.2018.03.013","article-title":"Monoallelic mutations to DNAJB11 cause atypical autosomal-dominant polycystic kidney disease","volume":"102","author":"Cornec-Le Gall","year":"2018","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cellsig.2020.109703_bb0055","first-page":"457","article-title":"Histogenesis of the renal cysts in adult (autosomal dominant) polycystic kidney disease: a histochemical study","volume":"1","author":"Verani","year":"1988","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0060","first-page":"F169","article-title":"Expression of aquaporins-1 and -2 during nephrogenesis and in autosomal dominant polycystic kidney disease","volume":"271","author":"Devuyst","year":"1996","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.cellsig.2020.109703_bb0065","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease","volume":"354","author":"Grantham","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2020.109703_bb0070","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2215\/CJN.00330705","article-title":"Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes","volume":"1","author":"Grantham","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0075","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrneph.2016.135","article-title":"The importance of total kidney volume in evaluating progression of polycystic kidney disease","volume":"12","author":"Grantham","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0080","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1053\/j.ajkd.2018.11.001","article-title":"Addressing the need for clinical trial end points in autosomal dominant polycystic kidney disease: a report from the polycystic kidney disease outcomes consortium (PKDOC)","volume":"73","author":"Smith","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cellsig.2020.109703_bb0085","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1172\/JCI72272","article-title":"Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease","volume":"124","author":"Harris","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2020.109703_bb0090","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ki.2015.207","article-title":"A polycystin-centric view of cyst formation and disease: the polycystins revisited","volume":"88","author":"Ong","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109703_bb0095","doi-asserted-by":"crossref","first-page":"109495","DOI":"10.1016\/j.cellsig.2019.109495","article-title":"Metabolic reprogramming and the role of mitochondria in polycystic kidney disease","volume":"67","author":"Podrini","year":"2019","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cellsig.2020.109703_bb0100","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ki.1987.121","article-title":"Cyst formation and growth in autosomal dominant polycystic kidney disease","volume":"31","author":"Grantham","year":"1987","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109703_bb0105","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1046\/j.1523-1755.2003.00242.x","article-title":"Lillian Jean Kaplan international prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: a systems biology approach","volume":"64","author":"Grantham","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109703_bb0110","first-page":"191","article-title":"Net fluid secretion in proximal straight renal tubules in vitro: role of PAH","volume":"226","author":"Grantham","year":"1974","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.cellsig.2020.109703_bb0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1172\/JCI117638","article-title":"In vitro fluid secretion by epithelium from polycystic kidneys","volume":"95","author":"Grantham","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2020.109703_bb0120","first-page":"1314","article-title":"Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease","volume":"2011","author":"Terryn","year":"1812","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cellsig.2020.109703_bb0125","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MNH.0b013e3283621510","article-title":"Osmoregulation, vasopressin, and cAMP signaling in autosomal dominant polycystic kidney disease","volume":"22","author":"Devuyst","year":"2013","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.cellsig.2020.109703_bb0130","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJM196910302811804","article-title":"Composition of fluid in twelve cysts of a polycystic kidney","volume":"281","author":"Gardner","year":"1969","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2020.109703_bb0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ki.1987.13","article-title":"Renal excretion and cyst accumulation of beta 2microglobulin in polycystic kidney disease","volume":"31","author":"Birenboim","year":"1987","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109703_bb0140","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1172\/JCI112155","article-title":"In vitro function of cyst epithelium from human polycystic kidney","volume":"76","author":"Perrone","year":"1985","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2020.109703_bb0145","first-page":"F420","article-title":"Reversed polarity of Na(+) -K(+) -ATPase: mislocation to apical plasma membranes in polycystic kidney disease epithelia","volume":"260","author":"Wilson","year":"1991","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.cellsig.2020.109703_bb0150","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-5347(17)44156-5","article-title":"Reduction of cyst volume for symptomatic management of autosomal dominant polycystic kidney disease","volume":"137","author":"Bennett","year":"1987","journal-title":"J. Urol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0155","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM199307293290503","article-title":"The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease","volume":"329","author":"Ye","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2020.109703_bb0160","first-page":"F381","article-title":"Anion secretion drives fluid secretion by monolayers of cultured human polycystic cells","volume":"269","author":"Mangoo-Karim","year":"1995","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.cellsig.2020.109703_bb0165","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/ki.1996.445","article-title":"Chloride and fluid secretion by cultured human polycystic kidney cells","volume":"50","author":"Wallace","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109703_bb0170","first-page":"C389","article-title":"A role for CFTR in human autosomal dominant polycystic kidney disease","volume":"270","author":"Hanaoka","year":"1996","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.cellsig.2020.109703_bb0175","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/ki.1996.304","article-title":"The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro","volume":"50","author":"Davidow","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109703_bb0180","doi-asserted-by":"crossref","first-page":"10206","DOI":"10.1073\/pnas.93.19.10206","article-title":"Immunolocalization of ion transport proteins in human autosomal dominant polycystic kidney epithelial cells","volume":"93","author":"Brill","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2020.109703_bb0185","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/MNH.0000000000000148","article-title":"Chloride secretion by renal collecting ducts","volume":"24","author":"Rajagopal","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.cellsig.2020.109703_bb0190","doi-asserted-by":"crossref","first-page":"17090","DOI":"10.1074\/jbc.RA119.010320","article-title":"Pharmacological reversal of renal cysts from secretion to absorption suggests a potential therapeutic strategy for managing autosomal dominant polycystic kidney disease","volume":"294","author":"Yanda","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2020.109703_bb0195","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/ki.2013.418","article-title":"Anoctamin 1 induces calcium-activated chloride secretion and proliferation of renal cyst-forming epithelial cells","volume":"85","author":"Buchholz","year":"2014","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109703_bb0200","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00109-020-01894-y","article-title":"TMEM16A drives renal cyst growth by augmenting Ca2+ signaling in M1 cells","volume":"98","author":"Cabrita","year":"2020","journal-title":"J Mol Med (Berl)."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109703_bb0205","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1681\/ASN.2013030209","article-title":"Hypoxia-inducible factor-1\u03b1 causes renal cyst expansion through calcium-activated chloride secretion","volume":"25","author":"Buchholz","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0210","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ki.2013.436","article-title":"ANO1: an additional key player in cyst growth","volume":"85","author":"Tanaka","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109703_bb0215","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00424-002-0880-3","article-title":"Basolateral chloride transporters in autosomal dominant polycystic kidney disease","volume":"444","author":"Lebeau","year":"2002","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.cellsig.2020.109703_bb0220","doi-asserted-by":"crossref","first-page":"F870","DOI":"10.1152\/ajprenal.00153.2003","article-title":"Histopathological analysis of renal cystic epithelia in the Pkd2WS25\/\u2212 mouse model of ADPKD","volume":"285","author":"Thomson","year":"2003","journal-title":"Am J Physiol Renal Physiol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0225","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ki.2008.246","article-title":"KCa3.1 potassium channels are critical for cAMP-dependent chloride secretion and cyst growth in autosomal-dominant polycystic kidney disease","volume":"74","author":"Albaqumi","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109703_bb0230","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature04712","article-title":"The ABC protein turned chloride channel whose failure causes cystic fibrosis","volume":"440","author":"Gadsby","year":"2006","journal-title":"Nature."},{"key":"10.1016\/j.cellsig.2020.109703_bb0235","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev.cb.08.110192.000435","article-title":"ABC transporters: from microorganisms to man","volume":"8","author":"Higgins","year":"1992","journal-title":"Annu. Rev. Cell Biol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0240","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1152\/physrev.1999.79.1.S23","article-title":"Structure and function of the CFTR chloride channel","volume":"79","author":"Sheppard","year":"1999","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cellsig.2020.109703_bb0245","doi-asserted-by":"crossref","unstructured":"Zhang Z, Liu F, Chen J. Conformational Changes of CFTR upon Phosphorylation and ATP Binding. Cell. 2017;170:483\u201391.e8.","DOI":"10.1016\/j.cell.2017.06.041"},{"key":"10.1016\/j.cellsig.2020.109703_bb0250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1513\/pats.2306011","article-title":"The cystic fibrosis transmembrane regulator forms macromolecular complexes with PDZ domain scaffold proteins","volume":"1","author":"Guggino","year":"2004","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.cellsig.2020.109703_bb0255","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1074\/jbc.M410026200","article-title":"Regulation of cystic fibrosis transmembrane regulator trafficking and protein expression by a rho family small GTPase TC10","volume":"280","author":"Cheng","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2020.109703_bb0260","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrm1949","article-title":"New insights into cystic fibrosis: molecular switches that regulate CFTR","volume":"7","author":"Guggino","year":"2006","journal-title":"Nat Rev Mol Cell Biol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12551-008-0002-3","article-title":"CFTR structure and function: is there a role in the kidney?","volume":"1","author":"Souza-Menezes","year":"2009","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.cellsig.2020.109703_bb0270","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1073\/pnas.88.20.9262","article-title":"Immunocytochemical localization of the cystic fibrosis gene product CFTR","volume":"88","author":"Crawford","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2020.109703_bb0275","first-page":"F723","article-title":"Developmental regulation of CFTR expression during human nephrogenesis","volume":"271","author":"Devuyst","year":"1996","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.cellsig.2020.109703_bb0280","first-page":"F1038","article-title":"Both the wild type and a functional isoform of CFTR are expressed in kidney","volume":"270","author":"Morales","year":"1996","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.cellsig.2020.109703_bb0285","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00424-008-0594-2","article-title":"CFTR and defective endocytosis: new insights in the renal phenotype of cystic fibrosis","volume":"457","author":"Jouret","year":"2009","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.cellsig.2020.109703_bb0290","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1681\/ASN.2006030269","article-title":"Cystic fibrosis is associated with a defect in apical receptor-mediated endocytosis in mouse and human kidney","volume":"18","author":"Jouret","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0295","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-1-61779-117-8_19","article-title":"Segmental and subcellular distribution of CFTR in the kidney","volume":"741","author":"Jouret","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0300","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0014-5793(98)00112-4","article-title":"CFTR mRNA and its truncated splice variant (TRN-CFTR) are differentially expressed during collecting duct ontogeny","volume":"423","author":"Huber","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cellsig.2020.109703_bb0305","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12551-014-0140-8","article-title":"CFTR and TNR-CFTR expression and function in the kidney","volume":"6","author":"Souza-Menezes","year":"2014","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.cellsig.2020.109703_bb0310","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1126\/science.1373908","article-title":"Regulation of plasma membrane recycling by CFTR","volume":"256","author":"Bradbury","year":"1992","journal-title":"Science."},{"key":"10.1016\/j.cellsig.2020.109703_bb0315","doi-asserted-by":"crossref","first-page":"13959","DOI":"10.1074\/jbc.M105441200","article-title":"Hyperacidification of cellubrevin endocytic compartments and defective endosomal recycling in cystic fibrosis respiratory epithelial cells","volume":"277","author":"Poschet","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2020.109703_bb0320","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1113\/JP270087","article-title":"Chloride transporters and receptor-mediated endocytosis in the renal proximal tubule","volume":"593","author":"Devuyst","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0325","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1056\/NEJMra043184","article-title":"Cystic fibrosis","volume":"352","author":"Rowe","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2020.109703_bb0330","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science."},{"key":"10.1016\/j.cellsig.2020.109703_bb0335","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0092-8674(90)90148-8","article-title":"Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis","volume":"63","author":"Cheng","year":"1990","journal-title":"Cell."},{"key":"10.1016\/j.cellsig.2020.109703_bb0340","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1469-1809.2003.00028.x","article-title":"The phenotypic consequences of CFTR mutations","volume":"67","author":"Rowntree","year":"2003","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.cellsig.2020.109703_bb0345","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jcf.2013.03.005","article-title":"A review of renal disease in cystic fibrosis","volume":"12","author":"Nazareth","year":"2013","journal-title":"Journal of Cystic Fibrosis\u202f: Official Journal of the European Cystic Fibrosis Society."},{"key":"10.1016\/j.cellsig.2020.109703_bb0350","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/adc.65.7.786","article-title":"Pseudo-Bartter\u2019s syndrome in cystic fibrosis","volume":"65","author":"Kennedy","year":"1990","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.cellsig.2020.109703_bb0355","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/BF01972891","article-title":"Chloride deficiency as a presentation or complication of cystic fibrosis","volume":"153","author":"Sojo","year":"1994","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.cellsig.2020.109703_bb0360","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1590\/S0001-37652000000300013","article-title":"The cystic fibrosis transmembrane regulator (CFTR) in the kidney","volume":"72","author":"Morales","year":"2000","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/j.cellsig.2020.109703_bb0365","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM198808043190502","article-title":"Microscopic nephrocalcinosis in cystic fibrosis","volume":"319","author":"Katz","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2020.109703_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(03)00403-7","article-title":"The association of nephrolithiasis with cystic fibrosis","volume":"42","author":"Gibney","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cellsig.2020.109703_bb0375","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00045391-199603000-00011","article-title":"Aminoglycoside-induced nephrotoxicity in cystic fibrosis: a case presentation and review of the literature","volume":"3","author":"Samaniego-Picota","year":"1996","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.cellsig.2020.109703_bb0380","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00424-011-1026-2","article-title":"Decreased renal accumulation of aminoglycoside reflects defective receptor-mediated endocytosis in cystic fibrosis and Dent\u2019s disease","volume":"462","author":"Raggi","year":"2011","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.cellsig.2020.109703_bb0385","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1569-1993(01)00004-2","article-title":"Subclinical anaemia of chronic disease in adult patients with cystic fibrosis","volume":"1","author":"O\u2019Connor","year":"2002","journal-title":"Journal of Cystic Fibrosis\u202f: Official Journal of the European Cystic Fibrosis Society."},{"key":"10.1016\/j.cellsig.2020.109703_bb0390","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1038\/s41598-017-05435-5","article-title":"Defective CFTR leads to aberrant beta-catenin activation and kidney fibrosis","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2020.109703_bb0395","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1171179","article-title":"cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells","volume":"11","author":"Hanaoka","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0400","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/j.1523-1755.2004.00967.x","article-title":"The relationship between cell proliferation, cl- secretion, and renal cyst growth: a study using CFTR inhibitors","volume":"66","author":"Li","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109703_bb0405","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1073\/pnas.0902661107","article-title":"Mouse cystic fibrosis transmembrane conductance regulator forms cAMP-PKA-regulated apical chloride channels in cortical collecting duct","volume":"107","author":"Lu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2020.109703_bb0410","doi-asserted-by":"crossref","unstructured":"Magenheimer BS, St John PL, Isom KS, Abrahamson DR, De Lisle RC, Wallace DP et al. Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator\/Na(+),K(+),2Cl(\u2212) Co-transporter-dependent cystic dilation. J. Am. Soc. Nephrol. 2006;17:3424\u201337.","DOI":"10.1681\/ASN.2006030295"},{"key":"10.1016\/j.cellsig.2020.109703_bb0415","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1681\/ASN.2007070828","article-title":"Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease","volume":"19","author":"Yang","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0420","doi-asserted-by":"crossref","first-page":"F982","DOI":"10.1152\/ajprenal.00677.2011","article-title":"Endogenous concentrations of ouabain act as a cofactor to stimulate fluid secretion and cyst growth of in vitro ADPKD models via cAMP and EGFR-Src-MEK pathways","volume":"303","author":"Jansson","year":"2012","journal-title":"Am J Physiol Renal Physiol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0425","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00232-015-9832-7","article-title":"Ouabain Regulates CFTR-Mediated Anion Secretion and Na,K-ATPase Transport in ADPKD Cells","volume":"248","author":"Jansson","year":"2015","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0430","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000438606","article-title":"Regulation of CFTR expression and arginine vasopressin activity are dependent on Polycystin-1 in kidney-derived cells","volume":"38","author":"de Lemos Barbosa","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.cellsig.2020.109703_bb0435","doi-asserted-by":"crossref","first-page":"C289","DOI":"10.1152\/ajpcell.01387.2000","article-title":"Extracellular ATP signaling and P2X nucleotide receptors in monolayers of primary human vascular endothelial cells","volume":"282","author":"Schwiebert","year":"2002","journal-title":"Am J Physiol Cell Physiol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0440","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11302-008-9102-6","article-title":"Purinergic signaling in the lumen of a normal nephron and in remodeled PKD encapsulated cysts","volume":"4","author":"Hovater","year":"2008","journal-title":"Purinergic Signalling."},{"key":"10.1016\/j.cellsig.2020.109703_bb0445","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1152\/physrev.1998.78.4.1165","article-title":"Epithelial transport in polycystic kidney disease","volume":"78","author":"Sullivan","year":"1998","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cellsig.2020.109703_bb0450","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.2174\/13816128113199990321","article-title":"CFTR inhibitors","volume":"19","author":"Verkman","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.cellsig.2020.109703_bb0455","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0272-6386(98)70072-1","article-title":"Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease","volume":"32","author":"O\u2019Sullivan","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cellsig.2020.109703_bb0460","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/joneph\/19.4.529","article-title":"Autosomal dominant polycystic kidney disease coexisting with cystic fibrosis","volume":"19","author":"Xu","year":"2006","journal-title":"Journal of Nephrology."},{"key":"10.1016\/j.cellsig.2020.109703_bb0465","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1681\/ASN.V11122285","article-title":"CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease","volume":"11","author":"Persu","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0470","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1021\/jm200505e","article-title":"Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-dione (BPO) CFTR inhibitors for polycystic kidney disease","volume":"54","author":"Snyder","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cellsig.2020.109703_bb0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058871","article-title":"Steviol reduces MDCK cyst formation and growth by inhibiting CFTR channel activity and promoting proteasome-mediated CFTR degradation","volume":"8","author":"Yuajit","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2020.109703_bb0480","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bcp.2014.01.038","article-title":"Steviol retards renal cyst growth through reduction of CFTR expression and inhibition of epithelial cell proliferation in a mouse model of polycystic kidney disease","volume":"88","author":"Yuajit","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0485","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bcp.2018.05.005","article-title":"Lansoprazole reduces renal cyst in polycystic kidney disease via inhibition of cell proliferation and fluid secretion","volume":"154","author":"Nantavishit","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0490","doi-asserted-by":"crossref","first-page":"11513","DOI":"10.1074\/jbc.RA118.001846","article-title":"A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector","volume":"293","author":"Yanda","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109703_bb0495","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000046231","article-title":"Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease","volume":"21","author":"Ecder","year":"2001","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0500","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ki.2008.357","article-title":"Let\u2019s look at cysts from both sides now","volume":"74","author":"Alper","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109703_bb0505","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ki.2009.438","article-title":"Cyclic nucleotide signaling in polycystic kidney disease","volume":"77","author":"Wang","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109703_bb0510","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1681\/ASN.2006010052","article-title":"PKD1 haploinsufficiency causes a syndrome of inappropriate antidiuresis in mice","volume":"18","author":"Ahrabi","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0515","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1681\/ASN.2006030251","article-title":"Increased water intake decreases progression of polycystic kidney disease in the PCK rat","volume":"17","author":"Nagao","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0520","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1681\/ASN.2007060688","article-title":"Vasopressin directly regulates cyst growth in polycystic kidney disease","volume":"19","author":"Wang","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109703_bb0525","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Czerwiec FS; TEMPO 3:4 trial investigators: Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2020.109703_bb0530","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Sergeyeva O; REPRISE trial investigators: Tolvaptan in later-stage autosomal dominant polycystic kidney disease","volume":"377","author":"Torres","year":"2017","journal-title":"N. Engl. J. Med."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656820301807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656820301807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:14:47Z","timestamp":1786634087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656820301807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":106,"alternative-id":["S0898656820301807"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2020.109703","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting chloride transport in autosomal dominant polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2020.109703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109703"}}